News
06-07-2010, 10:41 PM
ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque and first author of the abstract, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)," (Abstract #10004) presented in an oral session today updated positive data from PICASSO.
More... (http://www.news-medical.net/news/20100608/ZIOPHARM-presents-positive-data-from-PICASSO-Phase-II-trial-for-soft-tissue-sarcoma-at-46th-ASCO.aspx)
More... (http://www.news-medical.net/news/20100608/ZIOPHARM-presents-positive-data-from-PICASSO-Phase-II-trial-for-soft-tissue-sarcoma-at-46th-ASCO.aspx)